Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $337.7500 (-1.97%) ($335.4200 - $346.6400) on Tue. Mar. 13, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.06% (three month average) | RSI | 73 | Latest Price | $337.7500(-1.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | Factors Impacting REGN price | REGN will decline at least -1.03% in a week (0% probabilities). UUP(-10%) VIXM(-6%) TLT(-6%) TIP(-1%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.03% (StdDev 2.06%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
5 Day Moving Average | $339.84(-0.61%) | 10 Day Moving Average | $334.36(1.01%) | 20 Day Moving Average | $329.61(2.47%) | To recent high | -14.2% | To recent low | 6.9% | Market Cap | $35.811b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |